TY - JOUR
T1 - Evolução da prevalência de infecção por COVID-19 no Rio Grande do Sul, Brasil
T2 - Inquéritos sorológicos seriados
AU - Hallal, Pedro Curi
AU - Horta, Bernardo L.
AU - de Barros, Aluísio Jardim Dornellas
AU - Dellagostin, Odir A.
AU - Hartwig, Fernando P.
AU - Pellanda, Lúcia C.
AU - Struchiner, Cláudio José
AU - Burattini, Marcelo N.
AU - da Silveira, Mariângela Freitas
AU - Menezes, Ana M.B.
AU - Barros, Fernando C.
AU - Victora, Cesar Gomes
N1 - Publisher Copyright:
© 2020, Associacao Brasileira de Pos - Graduacao em Saude Coletiva. All rights reserved.
PY - 2020/6
Y1 - 2020/6
N2 - COVID-19, the disease produced by the virus SARS-CoV-2, has spread quickly throughout the world, leading the World Health Organization to first classify it as an internation-al health emergency and, subsequently, declaring it pandemic. The number of confirmed cases, as April 11, surpassed 1,700,000, but this figure does not reflect the prevalence of COVID-19 in the population as, in many countries, tests are almost exclusively performed in people with symptoms, particularly severe cases. To properly assess the magnitude of the problem and to contribute to the design of evidence-based policies for fighting COVID-19, one must accurately estimate the population prevalence of infection. Our study is aimed at estimating the prevalence of infected in-dividuals in the state of Rio Grande do Sul, Bra-zil, to document how fast the infection spreads, and to estimate the proportion of infected persons who present or presented symptoms, as well as the proportion of asymptomatic infections. Four repeated serological surveys will be conducted in probability samples of nine sentinel cities ev-ery two weeks. Tests will be performed in 4,500 participants in each survey, totaling18,000 inter-views. Interviews and tests will be conducted at the participants’ household. A rapid test for the detection of antibodies will be used; the test was validated prior to the beginning of the fieldwork.
AB - COVID-19, the disease produced by the virus SARS-CoV-2, has spread quickly throughout the world, leading the World Health Organization to first classify it as an internation-al health emergency and, subsequently, declaring it pandemic. The number of confirmed cases, as April 11, surpassed 1,700,000, but this figure does not reflect the prevalence of COVID-19 in the population as, in many countries, tests are almost exclusively performed in people with symptoms, particularly severe cases. To properly assess the magnitude of the problem and to contribute to the design of evidence-based policies for fighting COVID-19, one must accurately estimate the population prevalence of infection. Our study is aimed at estimating the prevalence of infected in-dividuals in the state of Rio Grande do Sul, Bra-zil, to document how fast the infection spreads, and to estimate the proportion of infected persons who present or presented symptoms, as well as the proportion of asymptomatic infections. Four repeated serological surveys will be conducted in probability samples of nine sentinel cities ev-ery two weeks. Tests will be performed in 4,500 participants in each survey, totaling18,000 inter-views. Interviews and tests will be conducted at the participants’ household. A rapid test for the detection of antibodies will be used; the test was validated prior to the beginning of the fieldwork.
KW - Brazil
KW - COVID-19
KW - Infection
KW - Population-based study
KW - Prevalence
UR - http://www.scopus.com/inward/record.url?scp=85086168874&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85086168874&partnerID=8YFLogxK
U2 - 10.1590/1413-81232020256.1.09632020
DO - 10.1590/1413-81232020256.1.09632020
M3 - Article
C2 - 32520284
AN - SCOPUS:85086168874
SN - 1413-8123
VL - 25
SP - 2395
EP - 2401
JO - Ciencia e Saude Coletiva
JF - Ciencia e Saude Coletiva
ER -